Lynx Investment Advisory Pfizer Inc Transaction History
Lynx Investment Advisory
- $150 Billion
- Q1 2025
A detailed history of Lynx Investment Advisory transactions in Pfizer Inc stock. As of the latest transaction made, Lynx Investment Advisory holds 47,782 shares of PFE stock, worth $1.16 Million. This represents 0.81% of its overall portfolio holdings.
Number of Shares
47,782
Previous 31,161
53.34%
Holding current value
$1.16 Million
Previous $827 Million
46.46%
% of portfolio
0.81%
Previous 0.56%
Shares
4 transactions
Others Institutions Holding PFE
# of Institutions
3,371Shares Held
3.61BCall Options Held
102MPut Options Held
130M-
Vanguard Group Inc Valley Forge, PA523MShares$12.7 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.3 Billion0.27% of portfolio
-
State Street Corp Boston, MA297MShares$7.18 Billion0.32% of portfolio
-
Geode Capital Management, LLC Boston, MA126MShares$3.04 Billion0.26% of portfolio
-
Wellington Management Group LLP Boston, MA103MShares$2.5 Billion0.52% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $136B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...